Notas del episodio
AI is no longer just for writing emails; it’s now designing the actual medicine you take in a massive $2.7 billion move. But while AI is busy curing diseases, a new study warns that your favorite chatbot might be making you a bit too full of yourself by agreeing with everything you say.
We’ll talk about:
- How Eli Lilly is using AI-generated drug candidates to change how we invent new medicines.
- A Stanford warning on why AI's constant validation is making us less likely to apologize or think critically.
- The secret project to combine ChatGPT, coding, and web browsing into one single powerhouse app.
- Why recruiters are banning AI from the hiring process and what it means for your next job application.
Keywords: Eli Lilly, Insilico Medicine, OpenAI Superapp, ChatGPT Ads, AI Sycophanc ...
Palabras clave
Agentic AIOpen Source AIChatGPT adsAI SycophancyOpenAI SuperappInsilico MedicineEli Lilly